Monoclonal antibodies and targeting them against cancer cells in lymphoma
Monoclonal antibodies and targeting them against cancer cells in lymphoma
Neo-angiogenesis and pathological angiogenesis in targeted molecules
Role of microenvironment and stroma in cancer therapy
Science behind phase I clinical trials: targeting tumour cell development pathways
ASCO 2013 highlights
Crizotinib superior to chemo for advanced ALK positive NSCLC
Ganetespib inhibits Hsp90 effective as second-line therapy with docetaxel for advanced lung cancer
Cetuximab superior to bevacizumab for advanced colorectal cancer
New targets for squamos cell carcinoma
European Thoracic Oncology Platform
Diagnosis and treatment in rare cases of thymoma
Integrating breast cancer genomics and proteomics